Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease Ziyan Pan; Moutaz Derbala; Khalid AlNaamani; Hasmik Ghazinian; Jian-Gao Fan; Mohammed Eslam;

NAFLD VS MAFLD. The evidence-based debate has come. Time to change? Diego García-Compeán; Alan Rafael Jiménez-Rodríguez;